Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review
Fentanyl and its derivatives sufentanil, alfentanil, and remifentanil are potent opioids. A
comprehensive review of the use of fentanyl and its derivatives in the pediatric population …
comprehensive review of the use of fentanyl and its derivatives in the pediatric population …
[HTML][HTML] Clinical pharmacology of fentanyl in preterm infants. A review
GM Pacifici - Pediatrics & Neonatology, 2015 - Elsevier
Fentanyl is a synthetic opioid that is very important in anesthetic practice because of its
relatively short time to peak analgesic effect and the rapid termination of action after small …
relatively short time to peak analgesic effect and the rapid termination of action after small …
Rapidly maturing fentanyl clearance in preterm neonates
S Völler, RB Flint, P Andriessen, K Allegaert… - Archives of Disease in …, 2019 - fn.bmj.com
Background Fentanyl is frequently used off-label in preterm newborns. Due to very limited
pharmacokinetic and pharmacodynamic data, fentanyl dosing is mostly based on …
pharmacokinetic and pharmacodynamic data, fentanyl dosing is mostly based on …
Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice
S Lundeberg, JA Roelofse - Pediatric Anesthesia, 2011 - Wiley Online Library
Sufentanil is a potent synthetic opioid. Like other opioids, sufentanil creates a stable
hemodynamic environment in cardiovascularly compromised pediatric patients. Clearance …
hemodynamic environment in cardiovascularly compromised pediatric patients. Clearance …
A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach
E Encinas, R Calvo, JC Lukas, V Vozmediano… - Pediatric drugs, 2013 - Springer
Abstract Background and Objectives Fentanyl is a synthetic opioid commonly used as an
anesthetic and also increasingly popular as a sedative agent in neonates. Initial dosage …
anesthetic and also increasingly popular as a sedative agent in neonates. Initial dosage …
Changes in sufentanil pharmacokinetics within the neonatal period
WJ Greeley, NP de Bruijn - Anesthesia & Analgesia, 1988 - journals.lww.com
Decreased clearance rate and increased elimination half-life of the synthetic narcotics,
sufentanil and fentanyl, have been reported in neonates when compared to older infants …
sufentanil and fentanyl, have been reported in neonates when compared to older infants …
Clinical pharmacokinetics of fentanyl and its newer derivatives
LE Mather - Clinical pharmacokinetics, 1983 - Springer
Fentanyl, a synthetic opiate with a (clinical) potency of 50 to 100 times that of morphine, was
introduced into clinical practice in the early 1960s. Usually administered by single …
introduced into clinical practice in the early 1960s. Usually administered by single …
Gestational age and birth weight effects on plasma clearance of fentanyl in newborn infants
E Saarenmaa, PJ Neuvonen, V Fellman - The Journal of pediatrics, 2000 - Elsevier
Objective: To provide a rational basis for the dosage of fentanyl in newborn infants by
determining clearance in the first days of life. Study design: A continuous infusion of fentanyl …
determining clearance in the first days of life. Study design: A continuous infusion of fentanyl …
Pharmacokinetics of fentanyl in neonates
DE Koehntop, JH Rodman, DM Brundage… - Anesthesia & …, 1986 - journals.lww.com
The pharmacokinetics of fentanyl were studied in fourteen neonates undergoing major
surgical procedures. Five patients were less than 1 day of age, seven ruere 1-4 days old …
surgical procedures. Five patients were less than 1 day of age, seven ruere 1-4 days old …
The use of ultra-short-acting opioids in paediatric anaesthesia: the role of remifentanil
PJ Davis, FP Cladis - Clinical pharmacokinetics, 2005 - Springer
Remifentanil is a synthetic opioid that was developed in the early 1990s and introduced into
clinical use in 1996. It is a methyl ester and is metabolised by nonspecific tissue and plasma …
clinical use in 1996. It is a methyl ester and is metabolised by nonspecific tissue and plasma …